ArticleCancer immunology, immunotherapy : CII2025
Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma.
Johannes Lutz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it